Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.

Hartmaier RJ, Tchatchou S, Richter AS, Wang J, McGuire SE, Skaar TC, Rae JM, Hemminki K, Sutter C, Ditsch N, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, Wappenschmidt B, Schmutzler RK, Meindl A, Bartram CR, Burwinkel B, Oesterreich S.

BMC Cancer. 2009 Dec 14;9:438. doi: 10.1186/1471-2407-9-438.

2.

Association of polymorphisms of angiogenesis genes with breast cancer.

Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, Lemler S, Nguyen AT, Hancock BA, Stout M, Skaar T, Flockhart DA.

Breast Cancer Res Treat. 2008 Sep;111(1):157-63. Epub 2007 Sep 20.

PMID:
17891484
3.

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

BMC Cancer. 2006 Sep 29;6:230.

4.

Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.

Yang R, Chen B, Hemminki K, Wappenschmidt B, Engel C, Sutter C, Ditsch N, Weber BH, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Burwinkel B.

Breast Cancer Res Treat. 2009 Nov;118(2):407-13. doi: 10.1007/s10549-009-0348-7. Epub 2009 Feb 20.

PMID:
19229607
5.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
6.

Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women.

Sterpone S, Mastellone V, Padua L, Novelli F, Patrono C, Cornetta T, Giammarino D, Donato V, Testa A, Cozzi R.

J Cancer Res Clin Oncol. 2010 Apr;136(4):631-6. doi: 10.1007/s00432-010-0791-1. Epub 2010 Feb 6.

PMID:
20140625
7.

Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.

Loizidou MA, Cariolou MA, Neuhausen SL, Newbold RF, Bashiardes E, Marcou Y, Michael T, Daniel M, Kakouri E, Papadopoulos P, Malas S, Hadjisavvas A, Kyriacou K.

Breast Cancer Res Treat. 2010 May;121(1):147-56. doi: 10.1007/s10549-009-0518-7. Epub 2009 Aug 28.

PMID:
19714462
8.

A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.

Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):955-60.

9.

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY.

Clin Cancer Res. 2005 Jul 1;11(13):4775-8.

10.

Single nucleotide polymorphisms in bone turnover-related genes in Koreans: ethnic differences in linkage disequilibrium and haplotype.

Kim KS, Kim GS, Hwang JY, Lee HJ, Park MH, Kim KJ, Jung J, Cha HS, Shin HD, Kang JH, Park EK, Kim TH, Hong JM, Koh JM, Oh B, Kimm K, Kim SY, Lee JY.

BMC Med Genet. 2007 Nov 26;8:70.

11.

Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.

Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N, Bugert P, Niederacher D, Meindl A, Schmutzler RK, Bartram CC, Ficarazzi F, Tizzoni L, Zaffaroni D, Manoukian S, Barile M, Pierotti MA, Radice P, Burwinkel B, Peterlongo P.

Hum Mutat. 2010 Jan;31(1):E1052-7. doi: 10.1002/humu.21141.

PMID:
19847796
12.

A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.

Freedman ML, Penney KL, Stram DO, Riley S, McKean-Cowdin R, Le Marchand L, Altshuler D, Haiman CA.

Cancer Res. 2005 Aug 15;65(16):7516-22.

13.

Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.

Huo X, Lu C, Huang X, Hu Z, Jin G, Ma H, Wang X, Qin J, Wang X, Shen H, Tang J.

J Cancer Res Clin Oncol. 2009 Nov;135(11):1569-75. doi: 10.1007/s00432-009-0604-6. Epub 2009 May 31.

PMID:
19484476
14.

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD.

J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. Epub 2007 Dec 11.

PMID:
18073375
15.

The HLA class III subregion is responsible for an increased breast cancer risk.

de Jong MM, Nolte IM, de Vries EG, Schaapveld M, Kleibeuker JH, Oosterom E, Oosterwijk JC, van der Hout AH, van der Steege G, Bruinenberg M, Boezen HM, Te Meerman GJ, van der Graaf WT.

Hum Mol Genet. 2003 Sep 15;12(18):2311-9. Epub 2003 Jul 22. Erratum in: Hum Mol Genet. 2003 Nov 15;12(22):3041.

PMID:
12915440
16.

Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.

Försti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K, Grzybowska E, Pamula J, Pekala W, Hallmans G, Lenner P, Hemminki K.

Breast Cancer Res Treat. 2007 Jan;101(1):83-93. Epub 2006 Jun 29.

PMID:
16807673
17.

Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk.

Han W, Kang SY, Kang D, Park SK, Lee JY, Kim H, Park AK, Noh DY.

Oncol Rep. 2010 Mar;23(3):763-9.

PMID:
20127018
18.

Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.

Wagner K, Hemminki K, Israelsson E, Grzybowska E, Klaes R, Chen B, Butkiewicz D, Pamula J, Pekala W, Försti A.

Endocr Relat Cancer. 2005 Dec;12(4):917-28.

19.

Germline RAP80 mutations and susceptibility to breast cancer.

Akbari MR, Ghadirian P, Robidoux A, Foumani M, Sun Y, Royer R, Zandvakili I, Lynch H, Narod SA.

Breast Cancer Res Treat. 2009 Jan;113(2):377-81. doi: 10.1007/s10549-008-9938-z. Epub 2008 Feb 28.

PMID:
18306035
20.

SNPs in ultraconserved elements and familial breast cancer risk.

Yang R, Frank B, Hemminki K, Bartram CR, Wappenschmidt B, Sutter C, Kiechle M, Bugert P, Schmutzler RK, Arnold N, Weber BH, Niederacher D, Meindl A, Burwinkel B.

Carcinogenesis. 2008 Feb;29(2):351-5. doi: 10.1093/carcin/bgm290. Epub 2008 Jan 3.

PMID:
18174240

Supplemental Content

Support Center